Haemoctin® becomes the company’s first biological product in the plasma-derived segment, offering a cost-effective alternative for the treatment of hemophilia in the region. This partnership reinforces SteinCares’ leadership in expanding access to...
The acquisition strengthens SteinCares’ leadership and operations in the country and is expected to contribute to the subsidiary’s growth. The deal includes the marketing and distribution license for a treatment for severe pain. San Jose, Costa Rica,...
SteinCares has strengthened its product portfolio in Colombia through an expanded agreement with Pharmacosmos for the commercialization and distribution of Monofer®, an innovative intravenous iron replacement therapy. This alliance reinforces SteinCares’...
The agreement includes the exclusive commercialization and distribution of Monofer® in selected countries in Latin America. This alliance strengthens SteinCares’ leadership as a strategic partner for global companies committed to the well-being of...
SteinCares assumes Sandoz’s portfolio in Colombia, strengthening its leading position in the Latin American specialty healthcare market. The agreement positions SteinCares to achieve over $50 million in sales in Colombia by 2024, establishing the country as the...
